Weekly Low-Dose Docetaxel in Advanced Hormone-Resistant Prostate Cancer Patients Previously Exposed to Chemotherapy - Concepedia

Concepedia

Publication | Closed Access

Weekly Low-Dose Docetaxel in Advanced Hormone-Resistant Prostate Cancer Patients Previously Exposed to Chemotherapy

27

Citations

22

References

2003

Year

Roberto Petrioli, Daniele Pozzessere, Simona Messinese, Marianna Sabatino, Teresa Di Palma, Stefania Marsili, Pierpaolo Correale, Antonio Manganelli, Francesco Salvestrini, Guido Francini

Abstract

Weekly low-dose docetaxel is an effective and well-tolerated treatment for patients with hormone-resistant prostate cancer previously exposed to chemotherapy.

References

	Year	Citations

Page 1